GGrantIndex
← Search

Phase I Clinical Trial of a Therapeutic for Gram Negative Bacteria Infection

$890,533N01FY2022AINIH

Dynport Vaccine Company, Llc, Frederick MD

Investigators

Abstract

The Phase I Clinical Trial Units provide a vehicle for the investigation of new therapeutic agents for the treatment of infectious disease.

View original record on NIH RePORTER →